Search Results 981-990 of 17848 for Assay
... assay demonstrating a high tumor mutation burden (≥ 10 mutations/Mb) and/or a high fraction of ultraviolet (UV) related mutations (> 50% of mutations ...
The Mayo Clinic Center for Individualized Medicine offers pharmacogenomic testing to better understand how your genes affect your body's response to ...
She uses in vitro T-cell stimulation assay and gnotobiotic mouse models to investigate the relationship between the gut microbiome and cancer treatment ...
Improved RT-PCR testing and serological assays — blood tests that identify antibodies or proteins present when the body is responding to infections such as ...
Locally assessed mutation status of KIT/PDGFRA must be available for patient stratification, using a tissue-based next-generation sequencing (NGS) or PCR assay.
... assays (Correlative Studies) of this protocol may be conducted. Submission of the tissue does not have to occur prior to randomization. Where local center ...
Stool studies must include a stool culture and Clostridium difficile toxin assay. These must have been performed during Screening or the current episode of ...
PKU is caused by a change in the gene that helps create an enzyme needed to break down phenylalanine. Treatment includes a special diet and medication.
Participants who are in complete remission from Hepatitis C as evidence by sensitive assay ≥ 12 weeks after completion of HCV therapy may participate in the ...
Positive Quantiferon (or other interferon gamma release assay) during Screening. Note: patients with indeterminant Quantiferon results may enroll. Known ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!